Blue Water Life Science Advisors, LP Care Dx, Inc. Transaction History
Blue Water Life Science Advisors, LP
- $103 Million
- Q3 2025
A detailed history of Blue Water Life Science Advisors, LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 510,000 shares of CDNA stock, worth $8.13 Million. This represents 7.18% of its overall portfolio holdings.
Number of Shares
510,000
Previous 724,014
29.56%
Holding current value
$8.13 Million
Previous $14.1 Million
47.59%
% of portfolio
7.18%
Previous 11.2%
Shares
11 transactions
Others Institutions Holding CDNA
# of Institutions
200Shares Held
54.5MCall Options Held
150KPut Options Held
57.6K-
Black Rock Inc. New York, NY5.29MShares$84.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.75MShares$59.8 Million0.0% of portfolio
-
Bamco Inc New York, NY3.16MShares$50.3 Million0.13% of portfolio
-
State Street Corp Boston, MA2.57MShares$40.9 Million0.0% of portfolio
-
Ophir Asset Management Pty LTD2.2MShares$35 Million4.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $852M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...